Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2020 May 31;160(5):1331–1345.e1. doi: 10.1016/j.jtcvs.2020.03.171

Figure 1.

Figure 1.

Schema for NRG Oncology trial 0229 (A) and NRG Oncology trial 0839 (B): both were prospective, multi-institutional phase II trials evaluating the efficacy of concurrent neoadjuvant chemotherapy and high-dose chest radiation prior to resection for stage III non-small cell lung cancer, with the primary endpoint of mediastinal nodal clearance. Randomization in NRG Oncology 0839 was 2:1 in favor of research arm.